5 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 1 with a minor change only.
Primary completion pushed from Jan 1, 2027 to Jan 1, 2028
Also in this update: Study completion pushed from Jul 1, 2027 to Jul 1, 2028
Mario Negri Institute for Pharmacological ResearchNot specified NCT07606209 Registry history of NCT07606209 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Jun 2026 to Jan 2027
Mario Negri Institute for Pharmacological ResearchNot specified NCT06372379 Registry history of NCT06372379 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Jun 2026 to Jan 2027
Mario Negri Institute for Pharmacological ResearchNot specified NCT06354764 Registry history of NCT06354764 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Mar 30, 2026 to Mar 30, 2027
Also in this update: Trial sites expanded: 5 → 9 locations; Study completion pushed from Jun 30, 2026 to Jun 30, 2027
Mario Negri Institute for Pharmacological ResearchNot applicable NCT07331103 Registry history of NCT07331103 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Aug 31, 2026 to Jan 31, 2027
Also in this update: Trial sites expanded: 24 → 59 locations
Mario Negri Institute for Pharmacological ResearchNot specified NCT07021118 Registry history of NCT07021118 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-18 | NCT07828054 Premedication With Dexamethasone for Preventing Interstitial Lung Disease in Patients… | Phase 3 | Not Yet Recruiting |
| Phase 2 | 4 | |
| Phase 2/3 | 1 | |
| Phase 3 | 2 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06121401 | First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive… | Carcinoma, Ovarian Epithelial | Active, Not Recruiting | 2026-06-25 |
| Phase 3 | ||||
| NCT06858280 | Patiromer and Diet/hrQoL in Chronic Dialysis | Hyperkalaemia | Recruiting | 2025-09-04 |
| NCT07828054 | Premedication With Dexamethasone for Preventing Interstitial Lung Disease in Patients… | Breast Cancer | Not Yet Recruiting | 2026-09-18 |
| Phase 2/3 | ||||
| NCT06126315 | Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS | Amyotrophic Lateral Sclerosis | Recruiting | 2026-10-06 |
| Phase 2 | ||||
| NCT06680050 | Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC… | Non Small Cell Lung Cancer NSCLC | Recruiting | 2025-12-18 |
| NCT05482945 | CardioPulmonary Resuscitation With Argon (CPAr) Trial | Cardiac Arrest, Out-Of-Hospital | Recruiting | 2025-09-17 |
| NCT07428018 | Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2… | Breast Cancer | Not Yet Recruiting | 2026-03-05 |
| NCT07233330 | Obinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome | Nephrotic Syndrome，Idiopathic | Not Yet Recruiting | 2026-01-26 |
| Not applicable | ||||
| NCT07331103 | RESOLving INflammation Through Diet for Health (RESOLVIN) | Cardiovascular (CV) Risk | Recruiting | 2026-10-09 |
| NCT05996731 | Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare… | Atypical Hemolytic Uremic Syndrome | Recruiting | 2026-03-23 |
| NCT05805202 | Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized… | Atypical Hemolytic Uremic Syndrome | Recruiting | 2025-09-29 |
| NCT06411353 | Blood Flow Conditions and Sounds in AVFs | End Stage Renal Disease | Recruiting | 2025-09-04 |
| NCT06884410 | Reproducibility of Multiparametric Renal Magnetic Resonance Imaging on 1.5T MRI Scanners | Multiparametric MRI | Recruiting | 2025-09-02 |
| NCT06374121 | Kidney Perfusion With or Without Absorption | Kidney Replacement | Recruiting | 2024-11-22 |
| NCT07596615 | Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence | Aging | Not Yet Recruiting | 2026-05-19 |
| NCT05985122 | New Analytic Tools for aHUS and C3G Diagnosis | Hemolytic-Uremic Syndrome | Active, Not Recruiting | 2026-03-23 |
| NCT07318025 | AVF-MONITOR POC Proof-of-concept Study | Hemodyalysis | Not Yet Recruiting | 2026-01-14 |
| NCT07270198 | Mechanisms Underlying SGLT2i Kidney Effect in DKD Progression | Diabetic Kidney Disease (DKD) | Not Yet Recruiting | 2025-12-08 |
| NCT05229263 | Multiparametric MRI in Healthy Volunteers and CKD Patients | Chronic Kidney Diseases | Active, Not Recruiting | 2025-03-26 |
| Not specified | ||||
| NCT04905264 | Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care | Brain Injuries, Acute | Recruiting | 2026-10-09 |
| NCT06354764 | Propensity to Hospitalize Patients From the ED in European Centers. | Emergency Medicine | Recruiting | 2026-10-09 |
| NCT06372379 | Development of a Multipurpose Dashboard to Monitor the Situation of Emergency Departments | Emergency Medicine | Recruiting | 2026-10-09 |
| NCT07021118 | Mild TBI in the Emergency Department | Emergency Departments | Recruiting | 2026-10-07 |
| NCT06240572 | Development of a Natural Language Processing Tool to Enable Clinical Research in… | Emergency Medicine | Recruiting | 2026-07-15 |
| NCT07683169 | Trauma Molecular Processes | Traumatic Brain Injury | Recruiting | 2026-07-06 |
Chronic Kidney Disease (6) · Breast Cancer (2) · Ovarian Cancer (2) · ALS (1) · Diabetes (1) · Heart Disease (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1)